Who Should Be Cautious With FOXO4-DRI Because there is no human safety data, the cautions below are drawn from the compound's mechanism and from general research practice, not from clinical findings
The dasatinib-plus- quercetin combination cleared senescent cells in a first-in-human trial, and a small feasibility trial is testing it in Alzheimers, though the brain evidence is early
Time to Get Your Energy Back Lifes too short to spend every day feeling exhausted
If you're already on a GLP-1 and interested in adding BPC-157, or want to explore both from the start, our medical team can evaluate your history, build a personalized plan, and provide pharmaceutical-grade compounds
Negrel R, Gaillard D, Ailhaud G